NewsBenzingaSepterna、Graves病および甲状腺眼症(TED)治療候補としてSEP-204を選定したと発表 2026年ATA年次総会でのポスター発表を前に初期前臨床データを報告 Septerna、Graves病および甲状腺眼症(TED)治療候補としてSEP-204を選定したと発表 2026年ATA年次総会でのポスター発表を前に初期前臨床データを報告 Benzinga 2026.11.04 13:04 (GMT+0) Open on Benzinga Other news TD Cowen Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $115 B. Riley Securities Maintains Buy on Almonty Indus, Lowers Price Target to $18 TD Cowen Maintains Hold on Elastic, Lowers Price Target to $85 B. Riley Securities Maintains Buy on AirJoule Technologies, Lowers Price Target to $6 UBS Maintains Buy on American Airlines Group, Raises Price Target to $17 If You Invested $1000 In State Street Technology Select Sector SPDR ETF Stock 15 Years Ago, You Would Have This Much Today
If You Invested $1000 In State Street Technology Select Sector SPDR ETF Stock 15 Years Ago, You Would Have This Much Today